Key result
Class III antiarrhythmic drugs are increasingly used for managing ventricular and supraventricular arrhythmias, with several new agents currently under investigation or regulatory review.
Population
Patients with cardiac arrhythmias, including those with ventricular arrhythmias and implantable cardioverter…
Design
Review
Authors
Loading...
May support adjunctive class III agents to reduce ICD shocks; leaves open need for randomized confirmation.
This review highlights the expanding clinical applications and recent pharmacological advances of class III antiarrhythmic drugs in managing both ventricular and supraventricular arrhythmias.
Philip T. Sager (2000) conducted a review in Cardiac arrhythmias. Class III antiarrhythmic drugs was evaluated. Class III antiarrhythmic drugs are increasingly used for managing ventricular and supraventricular arrhythmias, with several new agents currently under investigation or regulatory review.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: